The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.
Clinical trial NCT01627314 · TERMINATED
Trial details
- NCT number
- NCT01627314
- Sponsor
- Fate Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2016-03-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.